A61K 51/1063
The tumor cell being from stomach or intestines
Official title: {the tumor cell being from stomach or intestines}
A61K51/1063 (The tumor cell being from stomach or intestines) appears on 82 US grants and 82 published applications in this corpus.
Search patents in A61K- Granted patents
- 82
- Published applications
- 82
- Assignees
- 70
- Inventors
- 196
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 4 | 5 |
| 2006 | 2 | 3 |
| 2007 | 1 | 1 |
| 2008 | 4 | 6 |
| 2009 | 3 | 4 |
| 2010 | 4 | 5 |
| 2011 | 3 | 2 |
| 2012 | 2 | 6 |
| 2013 | 2 | 4 |
| 2014 | 1 | 3 |
| 2015 | 4 | 4 |
| 2016 | 2 | 8 |
| 2017 | 4 | 4 |
| 2018 | 3 | 4 |
| 2019 | 4 | 2 |
| 2020 | 4 | 3 |
| 2021 | 2 | 3 |
| 2022 | 3 | 2 |
| 2023 | 1 | 4 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5T4 binding polypeptides and uses thereof14 Apr 2026US 12,600,794 B2Abdera Therapeutics Inc.
- 18F-labeled novel tetrazines imaging probes for pretargeting in PET imaging18 Feb 2025US 12,226,495 B2Københavns Universitet
- NIR-conjugated tumor-specific antibodies and uses thereof31 Dec 2024US 12,178,887 B2City of Hope
- Conjugated biological molecules, pharmaceutical compositions and methods17 Sep 2024US 12,090,212 B2Obi Pharma, Inc.
- Monoclonal antibodies against Claudin-18 for treatment of cancer29 Aug 2023US 11,739,139 B2Astellas Pharma Inc.
- Conjugate and uses thereof30 Jul 2026US 2026/0216366 A1Full-Life Technologies UK Limited
- Production method of intermediate for radiopharmaceutical composition, and purification kit for intermediate for radiopharmaceutical composition25 Jun 2026US 2026/0174915 A1National Institutes for Quantum Science and Technology
- 5t4 binding polypeptides and uses thereof29 Jan 2026US 2026/0028414 A1Abdera Therapeutics Inc.
- Anti-ptk7 single-domain antibody and application thereof31 Oct 2024US 2024/0360248 A1Nanomab Technology Limited
- Monoclonal antibodies against claudin-18 for treatment of cancer11 Apr 2024US 2024/0117022 A1Astellas Pharma Inc.
Most cited
By later US patents
- Potentiation of cytotoxic conjugates103US 4,925,922 AXoma Corporation · 1990
- Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof87US 4,916,213 AXoma Corporation · 1990
- Production and use of novel peptide-based agents for use with bi-specific antibodies66US 6,962,702 B2Immunomedics, Inc. · 2005
- Modified antibodies63US 5,194,594 ATechniclone, Inc. · 1993
- Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods55US 5,367,080 ASterling Winthrop Inc. · 1994